Home » Topics » Regulatory

Regulatory
RSS

Columbia Laboratories issued U.S. patent for drug delivery technology

Sep. 23, 1997

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

Octreotide acetate clinical study commences for new indication

Sep. 23, 1997

Celgene's thalidomide approvable for ENL

Sep. 23, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...